from Reuters: Health News https://reut.rs/2BBJKPn
Johnson & Johnson's nasal spray for depression wins FDA panel backing
An advisory panel to the U.S. Food and Drug Administration on Tuesday voted in favor of Johnson & Johnson's experimental nasal spray, which has a compound similar to often-abused ketamine, bringing the drug closer to approval.
from Reuters: Health News https://reut.rs/2BBJKPn
from Reuters: Health News https://reut.rs/2BBJKPn
Subscribe to:
Post Comments (Atom)
-
The German cabinet will hold a secret session on Wednesday to discuss safeguard measures regarding the possible participation of China's...
-
Stocks poised for another day of gains Equity markets look to add to the gains from the prior session as investor concerns about the fu...
-
By LIAM STACK from NYT Magazine https://ift.tt/2FNPp6k
No comments:
Post a Comment